BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 16549839)

  • 1. Differential CD146 expression on circulating versus tissue endothelial cells in rectal cancer patients: implications for circulating endothelial and progenitor cells as biomarkers for antiangiogenic therapy.
    Duda DG; Cohen KS; di Tomaso E; Au P; Klein RJ; Scadden DT; Willett CG; Jain RK
    J Clin Oncol; 2006 Mar; 24(9):1449-53. PubMed ID: 16549839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High levels of circulating VEGFR2+ Bone marrow-derived progenitor cells correlate with metastatic disease in patients with pediatric solid malignancies.
    Taylor M; Rössler J; Geoerger B; Laplanche A; Hartmann O; Vassal G; Farace F
    Clin Cancer Res; 2009 Jul; 15(14):4561-71. PubMed ID: 19605404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of CD45-/CD31+/CD105+ circulating cells in the peripheral blood of patients with gynecologic malignancies.
    Yu HK; Lee HJ; Choi HN; Ahn JH; Choi JY; Song HS; Lee KH; Yoon Y; Yi LS; Kim JS; Kim SJ; Kim TJ
    Clin Cancer Res; 2013 Oct; 19(19):5340-50. PubMed ID: 23922300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discrimination between circulating endothelial cells and blood cell populations with overlapping phenotype reveals distinct regulation and predictive potential in cancer therapy.
    Starlinger P; Brugger P; Reiter C; Schauer D; Sommerfeldt S; Tamandl D; Kuehrer I; Schoppmann SF; Gnant M; Brostjan C
    Neoplasia; 2011 Oct; 13(10):980-90. PubMed ID: 22028623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of endothelial progenitor cells, distinct from mature endothelial cells, within human CD146+ blood cells.
    Delorme B; Basire A; Gentile C; Sabatier F; Monsonis F; Desouches C; Blot-Chabaud M; Uzan G; Sampol J; Dignat-George F
    Thromb Haemost; 2005 Dec; 94(6):1270-9. PubMed ID: 16411405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concurrent hypermulticolor monitoring of CD31, CD34, CD45 and CD146 endothelial progenitor cell markers for acute myocardial infarction.
    Shim Y; Nam MH; Hyuk SW; Yoon SY; Song JM
    Anal Chim Acta; 2015 Jan; 853():501-507. PubMed ID: 25467496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-time PCR of CD146 mRNA in peripheral blood enables the relative quantification of circulating endothelial cells and is an indicator of angiogenesis.
    Fürstenberger G; von Moos R; Senn HJ; Boneberg EM
    Br J Cancer; 2005 Oct; 93(7):793-8. PubMed ID: 16160694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cells meeting our immunophenotypic criteria of endothelial cells are large platelets.
    Strijbos MH; Kraan J; den Bakker MA; Lambrecht BN; Sleijfer S; Gratama JW
    Cytometry B Clin Cytom; 2007 Mar; 72(2):86-93. PubMed ID: 17252604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers of anti-angiogenic therapy in metastatic colorectal cancer (mCRC): original data and review of the literature.
    Pohl M; Werner N; Munding J; Tannapfel A; Graeven U; Nickenig G; Schmiegel W; Reinacher-Schick A
    Z Gastroenterol; 2011 Oct; 49(10):1398-406. PubMed ID: 21964893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determining circulating endothelial cells using CellSearch system during preoperative systemic chemotherapy in breast cancer patients.
    Ali AM; Ueno T; Tanaka S; Takada M; Ishiguro H; Abdellah AZ; Toi M
    Eur J Cancer; 2011 Oct; 47(15):2265-72. PubMed ID: 21737256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial progenitor cells, defined by the simultaneous surface expression of VEGFR2 and CD133, are not detectable in healthy peripheral and cord blood.
    Lanuti P; Rotta G; Almici C; Avvisati G; Budillon A; Doretto P; Malara N; Marini M; Neva A; Simeone P; Di Gennaro E; Leone A; Falda A; Tozzoli R; Gregorj C; Di Cerbo M; Trunzo V; Mollace V; Marchisio M; Miscia S
    Cytometry A; 2016 Mar; 89(3):259-70. PubMed ID: 26305912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased levels of viable circulating endothelial cells are an indicator of progressive disease in cancer patients.
    Beerepoot LV; Mehra N; Vermaat JS; Zonnenberg BA; Gebbink MF; Voest EE
    Ann Oncol; 2004 Jan; 15(1):139-45. PubMed ID: 14679134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of circulating VEGFR2+ bone marrow-derived progenitor cells in patients with advanced cancer.
    Massard C; Borget I; Le Deley MC; Taylor M; Gomez-Roca C; Soria JC; Farace F
    Eur J Cancer; 2012 Jun; 48(9):1354-62. PubMed ID: 22370181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased numbers of small circulating endothelial cells in renal cell cancer patients treated with sunitinib.
    Vroling L; van der Veldt AA; de Haas RR; Haanen JB; Schuurhuis GJ; Kuik DJ; van Cruijsen H; Verheul HM; van den Eertwegh AJ; Hoekman K; Boven E; van Hinsbergh VW; Broxterman HJ
    Angiogenesis; 2009; 12(1):69-79. PubMed ID: 19212818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mRNA levels of CD31, CD144, CD146 and von Willebrand factor do not serve as surrogate markers for circulating endothelial cells.
    Strijbos MH; van Krimpen BA; Debets R; Kraan J; Sleijfer S; Gratama JW; Lamers CH
    Thromb Haemost; 2010 Aug; 104(2):318-26. PubMed ID: 20589320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A subpopulation of circulating endothelial cells express CD109 and is enriched in the blood of cancer patients.
    Mancuso P; Calleri A; Gregato G; Labanca V; Quarna J; Antoniotti P; Cuppini L; Finocchiaro G; Eoli M; Rosti V; Bertolini F
    PLoS One; 2014; 9(12):e114713. PubMed ID: 25506915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive and prognostic significance of circulating endothelial cells in advanced non-small cell lung cancer patients.
    Yuan DM; Zhang Q; Lv YL; Ma XQ; Zhang Y; Liu HB; Song Y
    Tumour Biol; 2015 Nov; 36(11):9031-7. PubMed ID: 26084612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levels of circulating CD45(dim)CD34(+)VEGFR2(+) progenitor cells correlate with outcome in metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitors.
    Farace F; Gross-Goupil M; Tournay E; Taylor M; Vimond N; Jacques N; Billiot F; Mauguen A; Hill C; Escudier B
    Br J Cancer; 2011 Mar; 104(7):1144-50. PubMed ID: 21386843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Prospective Observational Study for Assessment and Outcome Association of Circulating Endothelial Cells in Clear Cell Renal Cell Carcinoma Patients Who Show Initial Benefit from First-line Treatment. The CIRCLES (CIRCuLating Endothelial cellS) Study (SOGUG-CEC-2011-01).
    García-Donas J; Leon LA; Esteban E; Vidal-Mendez MJ; Arranz JA; Garcia Del Muro X; Basterretxea L; González Del Alba A; Climent MA; Virizuela JA; Álvarez C; Sepúlveda J; Anido U; López C; Ortiz-Morales MJ; Pérez X; Rodriguez-Antona C; Rodriguez-Moreno JF; Hernando S; Castellano D
    Eur Urol Focus; 2017 Oct; 3(4-5):430-436. PubMed ID: 28753791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three specific antigens to isolate endothelial progenitor cells from human liposuction material.
    Hager G; Holnthoner W; Wolbank S; Husa AM; Godthardt K; Redl H; Gabriel C
    Cytotherapy; 2013 Nov; 15(11):1426-35. PubMed ID: 24094492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.